What is the treatment for hemicrania continua?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hemicrania Continua

Indomethacin is the definitive treatment for hemicrania continua, with therapeutic doses of 100-150 mg daily providing complete or near-complete resolution of symptoms in all cases. 1, 2, 3

Diagnostic Confirmation Through Treatment Response

  • Absolute response to indomethacin is required for diagnosis of hemicrania continua, making it both a diagnostic criterion and the primary treatment 1, 3
  • The response is typically rapid, with near-complete or complete resolution of headache and autonomic symptoms occurring within days of initiating therapy 4
  • Secondary headache causes must be ruled out before confirming the diagnosis and starting treatment 1

Standard Indomethacin Regimen

  • Start with indomethacin 100-150 mg daily as the standard therapeutic dose 2
  • Doses may range from 25-300 mg per day depending on individual response, though most patients respond to the 100-150 mg range 2, 5
  • Patients should be instructed to report changes in headache and autonomic symptoms after several days of treatment 4

Critical Problem: Long-Term Indomethacin Risks

The major clinical challenge is that indomethacin carries significant risks with both short-term and long-term use, making it a poor choice for continuous therapy despite its effectiveness. 2

  • Most patients cannot discontinue indomethacin without headache recurrence, creating a therapeutic dilemma 6
  • The risks of chronic NSAID use (gastrointestinal bleeding, cardiovascular events, renal toxicity) necessitate alternative approaches for long-term management 2

Alternative Medical Therapies

When indomethacin is contraindicated or poorly tolerated, consider these alternatives in order of evidence strength:

  • Amitriptyline: Effective in 66.6% of cases as prophylactic treatment 2
  • Gabapentin: Effective in 20% of cases 2
  • Topiramate: Effective in 10% of cases 2
  • Other reported alternatives include COX-2 inhibitors, piroxicam, beta-cyclodextrin, and melatonin, though evidence is limited to case reports 2

Important caveat: These alternatives are substantially less effective than indomethacin and should only be used when indomethacin cannot be tolerated 2

Interventional Procedures for Indomethacin-Dependent Patients

For patients who cannot discontinue indomethacin without recurrence, radiofrequency ablation procedures provide headache relief as complete as indomethacin with long-term efficacy. 6

Procedural Algorithm:

  1. Perform diagnostic blockade based on clinical examination and presence of cranial autonomic symptoms 6:

    • Atlanto-axial joint block
    • C2 dorsal root ganglion block
    • Sphenopalatine ganglion block
  2. If diagnostic block is positive, proceed to radiofrequency ablation of the corresponding target 6:

    • C2 ventral ramus
    • C2 dorsal root ganglion
    • Sphenopalatine ganglion
  3. Long-term follow-up shows patients remain essentially headache-free without indomethacin, though some may need repeat procedures 6

Clinical Presentation Features to Recognize

  • Continuous unilateral headache with ipsilateral cranial autonomic symptoms (lacrimation, conjunctival injection, nasal congestion, ptosis) 1, 3
  • Restlessness or agitation during exacerbations 3
  • Pain is continuous with superimposed exacerbations lasting minutes to days 5
  • May present with neuro-ophthalmologic symptoms requiring prompt recognition for early treatment initiation 4

Common Diagnostic Pitfall

Average time to correct diagnosis is 12 years, as patients often receive incorrect diagnoses before being properly evaluated 2. Consider hemicrania continua in any patient with continuous unilateral headache, normal neurological examination, and normal imaging, regardless of age of onset 2.

References

Guideline

Diagnosis and Treatment of Hemicrania Continua and Cluster Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of hemicrania continua: case series and literature review.

Revista brasileira de anestesiologia, 2012

Research

Hemicrania Continua: An Update.

Current pain and headache reports, 2023

Research

Neuro-ophthalmologic presentations of hemicrania continua.

American journal of ophthalmology, 2006

Research

Treatment of hemicrania continua with radiofrequency ablation and long-term follow-up.

Cephalalgia : an international journal of headache, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.